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Background: Due to growing antimalarial drug resistance, Tanzania changed malaria treatment policies twice
within a decade. First in 2001 chloroquine (CQ) was replaced by sulfadoxine-pyrimethamine (SP) for management
of uncomplicated malaria and by late 2006, SP was replaced by artemether-lumefantrine (AL). We assessed health
workers’ attitudes and personal practices following the first treatment policy change, at six months post-change
and two years later.
Methods: Two cross-sectional surveys were conducted in 2002 and 2004 among healthcare workers in three
districts in South-East Tanzania using semi-structured questionnaires. Attitudes were assessed by enquiring which
antimalarial was considered most suitable for the management of uncomplicated malaria for the three patient
categories: i) children below 5; ii) older children and adults; and iii) pregnant women. Practice was ascertained by
asking which antimalarial was used in the last malaria episode by the health worker him/herself and/or dependants.
Univariate and multivariate logistic regression was used to identify factors associated with reported attitudes and
practices towards the new treatment recommendations.
Results: A total of 400 health workers were interviewed; 254 and 146 in the first and second surveys, respectively.
SP was less preferred antimalarial in hospitals and private health facilities (p<0.01) in the first round, and the
preference worsened in the second round. In the first round, clinicians did not prefer SP for children below age of
5 and pregnant women (p<0.01), but two years later, they did not prefer it for all patient scenarios. SP was the
most commonly used antimalarial for management of the last malaria episode for health workers and their
dependants in both rounds, in the public sector (p<0.01). Health workers in the dispensaries had the highest odds
of using SP for their own treatment [adjusted OR- first round: 6.7 (95%CI: 1.9-23.4); crude OR- second
round: 4.5 (1.5-13.3)].
Conclusion: Following changes in malaria treatment recommendations, most health workers did not prefer the
new antimalarial drug, and their preferences worsened over time. However, many of them still used the newly
recommended drug for management of their own or family members’ malaria episode. This indicates that, other
factors than providers’ attitude may have more influence in their personal treatment practices.
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In early 2000, malaria was a leading cause of death in
hospitalized patients [1] and hospital attendances in
Tanzania, particularly among children under the age of
five and pregnant women [2]. During that time, Tanzania
recorded a range of 14–18 million clinical malaria cases
yearly, with a mortality rate of 140–165 per 100,000
people and approximately 70,000 to 100,000 deaths
among children under-five [1,2]. Malaria was endemic in
almost all parts of the country but with varying endem-
icity levels [3]. Current malaria control activities in the
country involve prompt diagnosis and treatment of
cases, intermittent preventive treatment for pregnant
women (IPTp), promoting the use of insecticide treated
bed-nets (ITNs), indoor residual spraying (IRS), moni-
toring and managing epidemics as well as environmental
management for vector control. However, the emergence
and spread of insecticide and antimalarial drugs resist-
ance may undermine the disease control strategies
already in place.
The pace at which malaria parasites develop resistance
to antimalarial drugs is alarming and necessitates inves-
tigating ways to prolong the lifespan of efficacious anti-
malarials [4,5]. The fact that drug resistance is a natural
and expected process, stresses the need for cost-effective
strategies to delay development of resistance, while con-
tinuing to provide effective treatment to those in need.
Fear that resistance will develop to drugs in use, is justi-
fiable and may provide a significant challenge to policy-
making decisions, initiating endless cycles of drug
replacement.
Towards the end of 2006, mainland Tanzania intro-
duced Artemisinin-based combination therapy (ACTs)
for routine management of uncomplicated malaria [6].
This was a second change of malaria treatment policy
within a decade. The first change occurred in August
2001 when chloroquine (CQ) was replaced by
sulfadoxine-pyrimethamine (SP) as the first line treat-
ment of uncomplicated malaria [2]. The changes were
necessary due to growing resistance of malaria parasites
to CQ [7]. At the time of change, SP was a second line
drug for treatment of malaria while quinine (QN) was
reserved for severe malaria. SP was one of the few inex-
pensive and relatively safe antimalarial drugs that was
still effective against chloroquine-resistant malaria [8].
SP was introduced on interim basis due to the fact that
resistance to SP had already been recorded in some parts
of the country [9-11]. Moreover, SP is known to be sus-
ceptible to resistance if used on a wide scale.
During the SP era, treatment guidelines indicated that
uncomplicated malaria should be treated with SP (sulfa-
doxine 500 mg with pyrimethamine 25 mg) as a single
dose based on age (above two months) and weight
(above 5 kg) [3]. Furthermore, the policy documentexplained how to recognize and manage non-response
to SP, contraindications, administration and adverse
effects of SP. In addition, the guideline explained that SP
should not be used in late pregnancy (36 weeks and
above) and for lactating mothers whose children are
below two months of age. Contraindications for use of
SP as stated in the guideline included history of sulfa-
doxine hypersensitivity, premature babies and children
below two months who were to receive QN. The policy
also explained when and how to use the second line
antimalarial drug, amodiaquine (AQ), for management
of uncomplicated malaria, including indications, contra-
indications, adverse reactions and dosage regimen [3].
At all levels of care, severe malaria was to be managed
with QN and where possible referred to a higher level of
care after a pre-referral quinine shot (intra-muscular).
Non responses to QN were to receive Artemisinin de-
rivative along with QN [9].
The introduction of SP for management of uncompli-
cated malaria in Tanzania was received with fear and
negative perceptions from both community and health
care workers [12]. Fear of side effects related to sulphur
content of the SP, was exacerbated by newspaper reports
of suspected victims of adverse drug reactions (ADR)
following use of SP. There was a chance that these fears
may have affected health provider’s acceptance of the
new treatment recommendations and behave inappro-
priately, since it is well understood that health workers’
performance can influence effectiveness of treatment
policies. Their actions may be a result of their own per-
ceptions of treatment efficacy. If a recommended treat-
ment is perceived to be effective, it is more likely to be
used as stipulated in the guideline whereas treatment
recommendations that do not measure up to their
expectations may be less utilized.
Contrary to expectations that health providers with
more training will more likely abide by evidence based
guidelines, Zurovac and colleagues reported that more
qualified health workers such as clinical officers and
nurses made more errors as compared to nurse aides by
using non-recommended antimalarials in treating un-
complicated malaria at government health facilities in
Kenya (OR 25.4; 95%CI 2.9-217.3 and OR=7.1 95%CI
1.1-44.5 respectively) [13]. In Ghana, Dodoo et al. con-
cluded that although first line treatment recommenda-
tions may change, clinical practice can still be influenced
by factors other than the decision or ability to diagnose
malaria [14]. Based on a longitudinal non-intervention
study to monitor adverse events, they found that age of
the patient, diagnostic confirmation and suspected con-
current conditions all had significant influence in clinical
practice.
Human beings tend to demand and use what is
perceived to be the best available option at a given time.
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best available treatment when managing their own ill-
nesses and their loved ones. Accurate information on
this practice may shed a light on how health providers’
preferences influence their practices. The need to assess
if providers’ attitude does influence their practices was
particularly high following introduction of SP since; first,
the change was not well received by providers and the
general population, and second, the change was on an
interim basis whilst evaluating other efficacious treat-
ment options. Understanding of this behavior would as-
sist policy making decisions for future treatment
changes in Tanzania and beyond.
Methods
Study design
This study was completed as part of the Interdisciplinary
Monitoring Project for Antimalarial Combination Treat-
ment in Tanzania (IMPACT-TZ). Data presented here
were collected in two cross sectional surveys aimed at
evaluating health workers’ understanding and utilization
of new treatment recommendations for use of SP as first
line treatment for management of uncomplicated mal-
aria. The evaluation was conducted in two steps: i) First
survey in February 2002 (approximately 6 months post-
change to SP) and ii) second survey in March 2004, two
years after the first survey. In both phases, semi-
structured questionnaires were used to assess healthFigure 1 Map of Tanzania showing study sites: Morogoro Rural, Rufij
IMPACT- Tanzania protocol).workers’ attitudes and practices related to the new
recommendations.Site description
The districts involved in the evaluation were Rufiji,
Morogoro Rural, Kilombero and Ulanga. For the pur-
pose of this evaluation, Kilombero and Ulanga (K/U)
were treated as a single unit because population move-
ment between these two districts is high. Rufiji and Mor-
ogoro rural are isolated from each other and movement
between them is limited by the Selous game reserve and
the long distances required to by-pass the game reserve
(Figure 1). The three districts are similar in terms of
urban, peri-urban and rural population proportions and
predicted intensity and duration of malaria transmission.
Based on data modeled by the Mapping Malaria Risk in
Africa (MARA) project, the three districts have a range
of 7–12 months of malaria transmission season
(Figure 2).
The Health and Demographic Surveillance Systems
(HDSS) were in place since 1998 in Rufiji and since
1996 for Ifakara DSS (which covers the districts of
Kilombero and Ulanga). In the first survey, data were
collected from three districts Morogoro Rural, Rufiji and
K/U. Two years later Rufiji district had started using
ACT, as part of the IMPACT-TZ project evaluation and
was hence excluded in the comparison between rounds.i, Ulanga and Kilombero districts (Source:
Figure 2 Patterns of malaria endemicity in Tanzania, 2002 (adopted from Tanzania Essential Health Interventions Project – TEHIP).
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In each district, one hospital, one or two health cen-
ters and three to four dispensaries that record a high
number of malaria cases were selected to participate.
The health facilities were purposively chosen based on
type, ownership, utilization rates and geographical lo-
cation. Selection of these facilities was done by the re-
search team in collaboration with the District Medical
Officer (DMO) using district health statistics and
maps.Eligibility criteria
Health workers from each selected facility were included
in this study if they were involved in prescribing and car-
ing for malaria patients. Interviews were conducted to
eligible health workers who were present and could
spare time for an interview (even after working hours),
on a day of visit. In both survey rounds, the same health
facilities were included, but no attempt was made to
match respondents between the two surveys.Data collection
Information was collected through face-to-face inter-
views using questionnaires. Questionnaires were origin-
ally developed in English and translated into Swahili,
then back translated to ensure accuracy. Trained local
field workers performed interviews in Swahili and later
that day, transcribed the responses into English. The
field guides had two parts: first were semi-structured
and open-ended questions while the second section had
case scenarios. The section with semi-structured ques-
tions asked about health workers’ understanding, atti-
tudes and practices relating to the new treatment
guidelines and needed a mention of antimalarial drug
from the interviewee as a response. The open-ended
questions enquired about challenges and problems faced
during the implementation of the new treatment policy
while the case scenarios were knowledge-based ques-
tions where a patient scenario was described and
required the health worker to narrate how that case
would be managed. Data analyzed in this report were
from the semi- structured part of the tool. Responses
Table 1 Characteristics of study participants for survey
rounds 1 and 2
Characteristic variable
Category
Total
Round 1 Round 2
n
254
%
100
n
146
%
100
District Morogoro 73 28.7 59 40.4
Rufiji 85 33.5 - -
K/Ulanga 96 37.8 87 59.6
Health facility ownership Public 105 41.3 79 54.1
Non-public 149 58.7 67 45.9
Health facility type Hospital 171 67.3 90 61.6
Health center 45 17.7 22 15.1
Dispensary 38 15 34 23.3
Cadre of health worker Physicians 6 2.4 8 5.4
Clinical Officers 51 20.1 26 17.8
Trained nurses 70 27.5 55 37.7
Other nurses 118 46.5 55 37.7
Others 9 3.5 2 1.4
Masanja et al. BMC Public Health 2012, 12:956 Page 5 of 14
http://www.biomedcentral.com/1471-2458/12/956from the open-ended and case scenario parts will be pre-
sented elsewhere.
Attitudes and practices
Questions to assess attitudes asked which antimalarial
drug was thought to be most suitable for management
of uncomplicated malaria for: i) children below 5, ii)
children above 5 years/adults and iii) pregnant women.
Health workers’ practices were assessed by asking what
antimalarial they or their dependants used the last time
they suffered malaria.
Data entry and analysis
Data were entered into EPI Info 2000 (CDC, Atlanta) by
a project statistician and verified by the project super-
visor through range and consistency checks for all
variables within each dataset separately. Original ques-
tionnaires were referred to whenever inconsistency, out-
liers or errors were encountered. Data from the two
surveys were stored in separate databases. Analysis was
done using STATA 10 (Stata Corporation, Texas). The
outcome variables for this paper were attitude and prac-
tice and risk factors were type of health worker, type of
health facility, facility ownership and district.
Definitions
Health workers were grouped into 5 categories; first
were physicians with a minimum of a medical degree or
advanced diploma in medicine, second were clinical offi-
cers (CO’s) with a diploma in medicine, third were
trained nurses (TN) which included all nurses with more
than two years of training i.e. registered and enrolled
nurses such as nurse midwives and nurse officers. All
other nurses, particularly with training of less than two
years (nurse assistants and nurse auxiliaries) were
grouped as “other nurses”. Other health workers e.g. la-
boratory assistant, who sees malaria patients only when
it is necessary, were termed as “other cadres”.
Attitudes towards the national malaria treatment
guidelines were assessed by comparing what health
workers considered the most appropriate antimalarial
for the three patient scenarios. If the response corre-
sponded to the recommendation in the guidelines it was
scored as “1” and “0” if not. Practice was assessed from
the reported antimalarial used by health workers them-
selves or their family members in their last malaria epi-
sode. Again, if the response corresponded to the
recommendation on the guideline it was scored as “1”
and “0” if not. Percentages were drawn and stratified by
district, type of health facility and type of health worker.
Percentages were used to describe the variables and
characteristics of study participants. For each of the
three scenarios, crude analyses of the associations be-
tween the various risk factors and the outcomes (attitudeand practice) were performed. In the univariate analysis,
cross tabulations and chi square tests were conducted to
identify possible confounders. Logistic regression was
used to build multivariate models to identify factors in-
dependently associated with each outcome. The group
with the higher number of respondents was regarded as
a reference in the multivariate analysis. Both crude and
adjusted odds ratios are presented.Ethical approval
Ethical clearance for the IMPACT- Tanzania project was
granted by the Ifakara Health Institute Review Board
and Tanzanian National Institute of Medical Research
(NIMR), in 2000.Results
Characteristics of study participants
In the first survey, 23 health facilities were visited in the
3 districts and 254 health workers were interviewed,
whereas in the second survey 16 health facilities within
2 districts were visited and 146 health workers were
interviewed (Table 1). There were fewer respondents
during the second survey, due to the exclusion of Rufiji
district. As shown in Table 1, K/U generally had the
highest percentage of participants in both phases. In the
first survey, a higher percentage of participants were
from non-public facilities (59%). In both rounds, hospi-
tals had the majority of study participants compared to
dispensaries and health centers (Table 1). The propor-
tion of physicians and ‘other’ cadres was small in both
surveys.
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Results in Table 2 shows that, in the first round, 44.1%
of providers reported to prefer SP for management of
uncomplicated malaria in children below five, 68% pre-
ferred SP for older children and adults and 51.6% pre-
ferred SP for pregnant women. Health workers in health
centers and dispensaries were more likely to report pre-
ferring SP than in hospitals (p<0.05) and more providers
from public facilities were in favor of SP than from non-
public health facilities; particularly for children and preg-
nant women; p<0.001 (Table 2). During the second
round, preference for SP treatments was very low in all
categories; with only 6.2% reporting to prefer SP for
management of uncomplicated malaria in children below
five, 5.5% preferred SP for older children and adults, and
only 4.1% preferred SP for pregnant women (Table 3).
There were no statistically significant differences in
reported preferences in almost all patients’ scenarios and
by different providers’ characteristics (Table 3).
Practices related to new recommended malaria treatment
Most health workers who had malaria episodes in the re-
cent past had used SP for treatment in both rounds; 55%
in round one and 60% in round two; indicating that, the
proportion of health workers who had used SP for man-
aging their own illnesses were higher in second survey
than the first; but fewer in absolute numbers. The excep-
tion was to health workers in non-public facilities
(Table 4). However, SP use for health workers depen-
dants declined in the second round. Only providers
working in dispensaries, public facilities and clinical offi-
cers recorded higher proportions of SP usage among
family members (Table 4).
The multivariate analysis (Table 5) shows that, com-
pared to providers at hospitals, working at dispensaries
and health centers were significant predictors of SP pre-
ference for older children and adults in the first round;
adjusted OR (aOR; 95% confidence interval) = 6.3 (1.8-
22.2) for dispensaries and aOR = 4.9 (1.7-14.0) for health
centers (Table 5). Poor SP preference was recorded in
non-public facilities with respect to management of un-
complicated malaria to pregnant women aOR= 0.2
(0.07-0.4) when compared to the public facilities. Non-
public facilities had consistently lower odds of SP prefer-
ences both in a crude and adjusted analysis (Table 5). In
terms of use, only providers at dispensaries had statisti-
cally significant higher odds of using SP in the last ill-
ness episode of a family member than those working in
the hospitals aOR= 6.7 (1.9-23.4).
In the second round (Table 6), only providers from
dispensaries showed higher odds of using SP for man-
agement of their own [cOR= 5.5 (1.9-15.6)] or family
member illness episodes [cOR= 4.5 (1.5-13.3)] in un-
adjusted analysis, compared to providers from thehospitals. As well staff of non-public facilities showed
lower odds of SP use than those working in the public
facilities, in the crude analysis cOR =0.3 (0.1-0.5) for self
use and 0.2 (0.06-0.5) for family member.
Discussion
This study provided an opportunity to assess the influ-
ence of health workers’ attitude to the usage of new
malaria treatment recommendations. Overall, results
showed variations in health workers attitudes and prac-
tices regarding new treatment recommendations in
terms of type of health facility, ownership and type of
health worker at six months post changes and two years
later. There was less variation of provider’s attitudes and
personal use of new recommended antimalarial between
districts. Dispensaries and health centers showed higher
preferences for SP than hospitals. Similarly, public facil-
ities reported higher preference for SP than non-public
ones. Most providers were not comfortable with the use
of SP for children below age of 5 and for pregnant
women. Personal use of SP for their malaria episodes
was high in both rounds, with some exceptions in the
second round.
The introduction of SP as a first line treatment of un-
complicated malaria in Tanzania was not well received
[12]. It is therefore not surprising that from the first sur-
vey (baseline), preference to SP as appropriate treatment
for management of uncomplicated malaria was low
among health workers in the surveyed districts. Their
dissatisfaction of treatment recommendation could have
influenced their perceptions, attitudes and practices.
This attitude may be based on their daily experiences in
the clinical management of patients as became evident
when we assessed providers’ preferences by type of
health facility. In many areas especially rural Tanzania,
hospitals are expected to be receiving referal cases. For
malaria, these could mean patients who did not respond
well to first line treatment at lower level of care, i.e. dis-
pensary or health center, hence sent to hospitals for fur-
ther management including laboratory assessment and
in-patients’ service. This may explain the significant
findings of providers from dispensaries and health work-
ers appreciating SP use better than hospitals.
Many studies have assessed users’ perceptions of new
treatments when changes occur. Several authors
explored community perceptions to malaria treatment
and other aspects of health services in Tanzania and
elsewhere [15-17]. Likewise, most studies of health
workers’ knowledge, perceptions, attitudes and under-
standing have been conducted in relation to health ser-
vices and health problems other than malaria [18-20].
The introduction of ACTs in most African countries
received considerable attention, with researchers evalu-
ating the process of change and performance of health
Table 2 Proportion of health workers who thought SP was appropriate treatment for uncomplicated malaria, year 2002
Character
variable
Category
(N=254)
Children<5 n (%) p-value Older children/ adults n (%) p-value Pregnant women n (%) p-value
SP:
n=112
(44.1)
*Other
drug:
n=139
(54.7)
DK/
Missing:
n=3 (1.2)
SP:
n=173
(68)
*Other
drug:
n=79
(31.1)
DK/
Missing:
n=2 (0.8)
SP:
n=131
(51.6)
*Other
drug:
n=116
(45.7)
DK/
Missing:
n=7 (2.7)
District Morogoro (73) 33 (45.2) 39 (53.4) 1 (1.3) 0.662 48 (65.8) 25 (34.2) - 0.085 27 (36.9) 44 (60.3) 2 (2.7) 0.032
Rufiji (85) 38 (44.7) 45 (52.9) 2 (2.3) 64 (75.3) 19 (22.4) 2 (2.3) 53 (62.4) 30 (35.3) 2 (2.3)
K/Ulanga (96) 41 (42.7) 55 (57.3) - 61 (63.5) 35 (36.5) - 51 (53.1) 42 (43.7) 3 (3.1)
Health facility
type
Hospitals (93) 39 (34.5) 53 (64.3) 1 (1.2) <0.001 103 (60.2) 66 (38.6) 2 (1.2) 0.049 72 (42.1) 92 (53.8) 7 (4.1) <0.001
Health Centers (45) 27 (60.0) 17 (37.8) 1 (2.2) 37 (82.2) 8 (17.8) - 31 (68.9) 14 (31.1) -
Dispensaries (38) 26 (68.4) 12 (31.6) - 33 (86.8) 5 (13.2) - 28 (73.7) 10 (26.3) -
HF ownership Public (176) 92 (52.3) 82 (46.6) 2 (1.1) <0.001 126 (71.6) 49 (27.8) 1 (0.6) 0.189 113 (64.2) 59 (33.5) 4 (2.3) <0.001
Non-public (78) 20 (25.6) 57 (73.1) 1 (1.3) 47 (60.3) 30 (38.5) 1 (1.3) 18 (23.1) 57 (73.1) 3 (3.8)
Cadre of health
worker
Physicians (6) 0 6 (100) - <0.001 5 (83.3) 1(16.7) - 0.01 - 6 (100) - 0.007
Clinical Officers (51) 22 (43.1) 29 (56.9) - 38 (74.5) 13 (25.5) - 24 (47.1) 27 (52.9) -
Trained nurses (70) 25 (35.7) 45 (64.3) - 43 (61.4) 27 (38.6) - 30 (42.9) 38 (54.3) 2 (2.8)
Other nurses (118) 63 (53.4) 54 (45.8) 1 (0.8) 84 (71.2) 33 (27.9) 1 (0.9) 74 (62.7) 40 (33.9) 4 (3.4)
Other cadres (9) 2 (22.2) 5 (55.6) 2 (22.2) 3 (33.3) 5 (55.6) 1 (1.1) 3 (33.3) 5 (55.6) 1 (11.1)
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or any combination of these P-value: Chi squared test.
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Table 3 Health workers who thought SP was appropriate treatment for uncomplicated malaria year 2004
Characteristic
variable
Category
(N =146)
Children<5 n (%) p-value Older children/ adults n (%) p-value Pregnant women n (%) p-value
SP;
n=9
(6.2)
*Other
drug;
n=135
(92.5)
DK/
Missing;
n=2 (1.3)
SP;
n=8
(5.5)
*Other
drug;
n=138 (94.5)
SP;
n=6
(4.1)
*Other
drug
n=126
(86.3)
DK/
Missing
n=14 (9.6)
District Morogoro (59) 1 (1.7) 58 (98.3) 0 0.08 1 (1.7) 58 (98.3) 0.09 1 (1.7) 56 (94.9) 2 (3.4) 0.04
K/Ulanga (87) 8 (9.2) 77 (88.5) 2 (2.3) 7 (8.1) 80 (91.9) 5 (5.7) 70 (80.5) 12 (13.8)
Health facility
type
Hospitals (90) 9 (10.0) 79 (87.8) 2 (2.2) 0.11 8 (8.9) 82 (91.1) 0.07 6 (6.7) 73 (81.1) 11 (12.2) 0.18
H/Centers (22) 0 22 (100) 0 0 22 (100) 0 21 (95.5) 1 (4.5)
Dispensaries (34) 0 34 (100) 0 0 34 (100) 0 32 (94.1) 2 (5.9)
HF ownership Public (79) 4 (5.1) 75 (94.9) 0 0.24 4 (5.1) 75 (94.9) 0.81 3 (3.8) 71 (89.9) 5 (6.3) 0.33
Non-public (67) 5 (7.5) 60 (89.5) 2 (3.0) 4 (5.9) 63 (94.1) 3 (4.5) 55 (82.1) 9 (13.4)
Cadre of health
worker
Physicians (8) 0 8 (100) 0 0.56 0 8 (100) 0.48 0 8 (100) 0 0.41
Cl/ Officers (26) 0 26 (100) 0 0 26 (100) 0 23 (88.5) 3 (11.5)
Trained nurses (55) 5 (9.1) 48 (87.3) 2 (3.6) 5 (9.1) 50 (90.9) 5 (9.1) 43 (78.2) 7 (12.7)
Other nurses (55) 4 (7.3) 51 (92.7) 0 3 (5.5) 52 (94.5) 1 (1.8) 50 (90.9) 4 (7.3)
Other cadres (2) 0 2 (100) 0 0 2 (100) 0 2 (100) 0
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or a combination of these P-value: Chi squared test.
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Table 4 Personal and/ or family member use of SP for management of uncomplicated malaria in 2002 and 2004
Characteristic
variable
Category Self use
N=247(%)–(2002)
p-value Self use
N=81(%) –(2004)
p-value Own child/family
N= 207(%)-(2002)
p-value Own child/family
N=84 (%) (2004)
p-value
SP;
n=135
(54.7)
*Other
drug;
n=112
(45.3)
SP;
n=49
(60.5)
*Other
drug;
n=32
(39.5)
SP;
n=124
(59.9)
*Other
drug;
n=83
(40.1)
SP;
n=37
(44)
*Other
drug;
n=47
(55)
District Morogoro 41 (56.2) 32 (43.8) 0.48 22 (66.7) 11 (33.3) 0.34 35 (47.9) 26 (35.6) 0.41 12 (40.0) 18 (60.0) 0.57
Rufiji 43 (50.6) 38 (44.7) - - 48 (56.5) 23 (27.0) - -
K/Ulanga 51 (53.1) 42 (43.8) 27 (56.2) 21 (43.8) 41 (42.7) 34 (35.4) 25 (46.3) 29 (53.7)
Health facility
type
Hospitals 86 (50.3) 81 (47.4) 0.16 22 (50.0) 22 (50.0) 0.08 68 (39.8) 67 (39.2) <0.001 16 (32.0) 34 (68.0) 0.01
Health Centers 24 (53.3) 18 (40.0) 12 (66.7) 6 (33.3) 26 (57.8) 12 (26.7) 6 (50.0) 6 (50.0)
Dispensaries 25 (65.8) 13 (34.2) 15 (78.9) 4 (21.1) 30 (78.9) 4 (10.5) 15 (68.2) 7(31.8)
HF ownership Public 99 (56.3) 72 (40.9) 0.30 35 (71.4) 14 (28.6) 0.01 100 (56.8) 52(29.6) <0.001 30 (58.8) 21 (41.2) 0.001
Non-public 36 (46.2) 40 (51.3) 14 (43.7) 18 (56.3) 24 (30.8) 31 (39.7) 7 (21.2) 26 (78.8)
Cadre of health
worker
Physicians 3 (50.0) 3 (50.0) 0.48 2 (100) 0 0.19 2 (33.3) 2 (33.3) 0.01 0 3 (100) 0.21
Clinical Officers 26 (51.0) 25 (49.0) 10 (83.3) 2 (16.7) 21 (41.2) 13 (25.5) 8 (66.7) 4 (33.3)
Trained nurses 34 (48.6) 34 (48.6) 18 (56.3) 14 (43.7) 28 (40.0) 29 (41.4) 11 (40.7) 16 (59.3)
Other nurses 69 (58.5) 45 (38.1) 19 (54.3) 16 (45.7) 66 (55.9) 38 (32.2) 18 (43.9) 23 (56.1)
Other cadres 3 (33.3) 5 (55.6) 0 0 7 (77.8) 1 (11.1) 0 1 (100)
*Other drugs includes: Chloroquine, Amodiaquine, Artemisinins, Quinine or a combination of these.
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Table 5 Health-workers attitude and personal (or/and family) use of SP for management of uncomplicated malaria, 2002
Characteristic
variable
Category Children<5:
OR (95%CI)
Older children/ adults:
OR (95%CI)
Pregnant women:
OR (95%CI)
Self use:
OR (95%CI)
Own child/family use:
OR (95%CI)
(N=254) Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR
District K/Ulanga (96) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Morogoro (73) 1.1 1.5‡ 1.1 0.9 ‡ 0.5 0.9‡ 0.9 1.1‡ 0.9 0.7‡
(0.6-2.0) (0.6-3.6) (0.6-2.1) (0.3-2.2) (0.3-0.9) (0.3-2.1) (0.5-1.8) (0.5-2.4) (0.5-1.8) (0.3-1.6)
Rufiji (85) 1.1 1.4‡ 1.7 2.0‡ 1.4 2.9‡ 0.9 0.9‡ 1.4 1.3‡
(0.6-1.9) (0.7-2.9) (0.9- 3.3) (0.9-4.4) (0.8 -2.6) (1.3-6.3) (0.5-1.7) (0.5- 1.9) (0.7-2.8) (0.6-2.7)
Health facility
type
Hospitals (93) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Health Centers (45) 2.8 2.1 Ɨ 3.1 4.9 Ɨ 3.0 2.1 Ɨ 1.2 1.2 Ɨ 1.7 1.8 Ɨ
(1.4-5.6) (0.9-4.7) (1.3-6.9) (1.7-14.0) (1.5-6.1) (0.9-4.9) (0.6-2.6) (0.5-2.6) (0.8-3.6) (0.6- 2.7)
Dispensaries (38) 4.1 2.4 Ɨ 4.3 6.3 Ɨ 3.8 2.3 Ɨ 1.5 1.3 Ɨ 5.4 6.7 Ɨ
(1.9-8.7) (0.9-6.1) (1.6-11.7) (1.8-22.2) (1.7-8.4) (0.8-6.6) (0.7-3.3) (0.5-3.4) (1.8-16.1) (1.9-23.4)
HF ownership Public (176) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Non-public (78) 0.3 0.8 ¥ 0.6 0.9 ¥ 0.1 0.2¥ 0.6 0.7 ¥ 0.6 1.2¥
(0.2-0.6) (0.4-1.7) (0.3-1.0) (0.4-2.1) (0.09-0.3) (0.07-0.4) (0.4-1.1) (0.3-0.5) (0.3-1.1) (0.5-2.7)
Cadre of health
worker
Other nurses (118) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Physicians (6) - - 2.0 3.8§ - - 0.6 0.8§ 0.9 1.3§
(0.2-17.9) (0.4-36.4) (0.1-3.2) (0.1-4.5) (0.2-5.4) (0.2-8.2)
Clinical Officers (51) 0.7 0.8 § 1.2 1.6§ 0.5 0.7§ 0.6 0.6§ 1.3 1.7§
(0.3-1.3) (0.4-1.6) (0.5-2.5) (0.7-3.6) (0.3-1.0) (0.3-1.4) (0.3-1.2) (0.3-1.3) (0.6-2.9) (0.8-3.7)
Trained nurses (70) 0.5 0.8§ 0.6 1.2§ 0.4 1.0§ 0.6 0.8§ 0.7 0.9 §
(0.3-0.9) (0.4-1.7) (0.3-1.2) (0.6-2.4) (0.2-0.8) (0.5-2.2) (0.3-1.2) (0.4-1.5) (0.3- 1.2) (0.5-1.9)
Other cadres (9) 0.2 0.1§(0.0 0.2 0.07§ 0.3 0.1§ 0.5 0.4§ 3.8 3.1§
(0.04-1.2) 3-0.8) (0.05-0.8) (0.02-0.4) (0.07-1.2) (0.02-0.6) (0.1-1.9) (0.1-1.7) (0.4-31.5) (0.3-27.1)
‡Adjusted for type of health facility, health facility ownership and health worker cadre.
Ɨ Adjusted for district, health facility ownership and health worker cadre.
¥ Adjusted for district, type of health facility and health worker cadre.
§ Adjusted for district, type of health facility and health facility ownership.
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Table 6 Health workers attitude and personal use (or/and family use) of SP for management of uncomplicated malaria, 2004
Characteristic
variable
Category
n=(146)
Children<5:
OR (95%CI)
Older children/adults:
OR (95%CI)
Pregnant women:
OR (95%CI)
Self use:
OR (95%CI)
Own child/family use:
OR (95%CI)
Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR Crude OR Adjusted OR
District Morogoro (59) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
K/Ulanga (87) 5.8 3.4 ‡ 5.1 2.7‡ 3.5 2.4‡ 1.2 0.5 ‡ 1.2 2.1‡
(0.7-48.3) (0.3-35.2) (0.7-42.4) (0.2-29.9) (0.4-31.1) (0.2-30.7) (0.5-2.2) (0.1-1.8) (0.5-3.2) (0.5-7.8)
Health facility
type
Hospitals (90) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
H/Centers (22) - - - - - - 1.6 0.7 Ɨ 2.1 0.8 Ɨ
(0.6-4.4) (0.1-3.9) (0.6-7.6) (0.1-4.1)
Dispensaries (34) - - - - - - 5.5 1.2 Ɨ 4.5 3.0 Ɨ
(1.9-15.6) (0.2-8.0) (1.5-13.3) (0.5-17.6)
HF ownership Public (79) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Non-public (67) 1.5 0.5¥ 1.2 0.4¥ 1.2 0.5¥ 0.3 0.2¥ 0.2 0.2¥
(0.4-5.8) (0.1-2.7) (0.3-4.9) (0.08-2.3) (0.2-6.0) (0.07-3.5) (0.1-0.5) (0.05-1.2) (0.06-0.5) (0.06-1.1)
Cadre of health
worker
Other nurses (55) Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
Physicians (8) - - - - - - 1.2 2.6§(0.5-13.5) - -
(0.2-5.5)
Clinical Officers (26) - - - - - - 1.9 1.4§ 0.8 1.3§
(0.7-5.4) (0.6-3.4) (0.3-2.3) (0.4-4.1)
Trained nurses (55) 1.2 0.8§ 1.7 1.0§ 5.4 (0.6-47.8) 3.6§ (0.3-34.9) 1.1 1.8§ (0.6-5.4) 2.5 3.1§
(0.3-5.0) (0.2-3.7) (0.4-7.6) (0.2- 5.4) (0.4-2.8) (0.6 -9.8) (0.4-14.2)
Other cadres (2) - - - - - - - - - -
‡Adjusted for type of health facility, health facility ownership and health worker cadre.
Ɨ Adjusted for district, health facility ownership and health worker cadre.
¥ Adjusted for district, type of health facility and health worker cadre.
§ Adjusted for district, type of health facility and health facility ownership.
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http://www.biomedcentral.com/1471-2458/12/956workers on new policies. Some of these evaluations were
on artemether-lumefantrine in Kenya, Uganda, and
Zambia as well as on artesunate plus amodiaquine in
Ghana [14,21-23]. These evaluation assessed providers’
use of new treatment recommendations for malaria case
management, with no focus on personal preferences and
personal use.
The difference in providers’ preferences for SP for
management of uncomplicated malaria may also be
related to performance of the health facilities governing
committees. A fact that public providers were more
comfortable with SP than those in the non-public sector
may be linked to a closer supervision of health manage-
ment teams. Intrinsically health workers do assess clin-
ical progress of their patients. Results in this survey
indicate that most providers were skeptical using SP for
children under 5, and pregnant women; probably be-
cause they perceived it too strong for children below age
of 5 as a previous study from Tanzania reported [15].
This preference worsened over time suggesting that pro-
viders were not satisfied with experiences of using SP.
This finding is in contrary to what one would expect;
that providers need time to appreciate, accept and com-
ply with new treatment policies. An important lesson
here is that, when there is a failing drug in the system,
health care providers will, without doubt, notice it and
may provide initial indication of the drug resistance in
the population.
Despite poor attitudes to the new drug for first line
management of uncomplicated malaria, many providers
indicated that they had used SP in their last illness epi-
sode of malaria. In the first round, it was difficult to as-
sess if SP was used before or after the change, since we
did not specify the duration of illness prior the survey,
but in the second round we gave a time frame; i.e. we
inquired for a malaria episode in the past three months
preceding the survey. Also, we did not seek additional
clinical information; therefore couldn’t assess if it was
correctly used. Interestingly, compared to hospitals, pro-
viders’ from the dispensaries were more likely to have
used SP for their illness episode or their family mem-
bers. This finding was observed in both survey rounds.
One possible explanation for this observation may be
related to a fact that, hospitals are a higher level of care,
therefore more likely to see referal cases of malaria; i.e.
non response to first line treatment and/or severe form
of the disease. But also, dispensaries do not have a wider
range of treatment choices and services available, hence
more likely to follow treatment guidelines presented.
Also, it is more likely that, knowing this is the only
available treatment option for them, dispensaries strives
to have medications available in stock; hence availability
of the drugs facilitated it being used by a staff or staff ’s
family member. This may not be a case for higher levelsof care, given a wider choice of drugs available. The
same may apply for public providers, with good health
management team supervision, public facilities are more
likely to abide by the new treatment recommendations,
but this cannot be said for non-public facilities, hence
significantly less use of SP for last malaria episodes was
observed from non-public providers in this study. SP
was available as a single dose and its price was not as
high as other antimalarials available at the time of sur-
vey. During this time, other antimalarials available in pri-
vate sector included amodiaquine, chloroquine (the
outgoing medicine), artemisinin mono-therapy, quinine,
etc. All of these products require more than a single
dose to finish a course of treatment, therefore more
likely to cost more than SP. A possibility of financial
gain for using other treatment recommendations than
SP cannot be ruled-out in the private sector.
Study limitations
We did not account for the clustering of health facilities
in the analysis. This may have affected the magnitude of
the measured effect. Ideally, this clustering effect should
be taken into account because there may be similarities
between individuals working in the same health facility,
such that, on average they are more similar to each other
than to individuals in other health facilities, due to many
factors such as training received at facility level and
experiences acquired through everyday’s practices. How-
ever, we worked with the assumption of independence
between the observations, since we were assessing indi-
viduals’ attitudes, through their preferences and personal
use of treatment recommendations. These variables are
more likely to be related to personal understanding and
beliefs.
However, it is acknowledged that personal preferences
can be influenced by many factors such as training, work
experience and for the case of malaria treatment; avail-
ability of medicines and appropriate technologies to as-
sist in clinical care of patients e.g. diagnostics for
malaria confirmation, as well as presence of policy briefs
and documents for referencing. These factors were not
assessed and therefore limit our conclusions with
regards to the role they play to shape health workers
preferences and personal use of new treatment recom-
mendations for management of uncomplicated malaria
in the surveyed area.
Third, a fact that the criteria used to obtain inter-
viewee was not random, implies that results from this
evaluation cannot be generalized for all health workers
in Tanzania. However, we are confident that, this study
provided additional information on predictors of prefer-
ences and practices among health care providers toward
SP, which complimented previous reports of poor com-
munity and provider’s perceptions towards SP when it
Masanja et al. BMC Public Health 2012, 12:956 Page 13 of 14
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aria in Tanzania; as well, it provides a clue on what hap-
pens to the health system when there is a failing drug.
Although we did not match respondents in the two
surveys, the fact that we interviewed health workers
from the same health facilities, increased our confidence
that the differences reported in preferences and practices
reflect a general picture for providers with similar
experiences.
Fourth, not being able to assess clinical information
when assessing practices towards recommended treat-
ment through personal/family use, might have led to a
biased estimation of SP use. It is possible that there were
good reasons for not using SP to some cases that may
be due to, for example, a diagnosis of severe malaria,
non-response to SP or history of hypersensitivity reac-
tion to sulphur- containing medicines.
Fifth, it is possible that some health workers reported
what was considered appropriate rather than what they
would actually do, or actually did, leading to courtesy
bias. Furthermore, recalling what happened in terms of
treating malaria in the past may have been difficult for
some participants, introducing a recall bias. These biases
could have affected measures of effect estimated. In this
respect, we limited the recall for up to the past three
months in the second survey.
Lastly, the relatively small sample for some sub-groups
of explanatory variables e.g. physicians; made it difficult
to detect associations between some potential risk fac-
tors and the outcomes studied in those groups.
Conclusion
Following changes in malaria treatment guidelines,
health workers in Morogoro Rural, Rufiji and K/U dis-
tricts showed variations in attitude towards new recom-
mendations. Health workers generally showed poor
attitudes towards the new recommended first line treat-
ment, but many used it in their last malaria episode or
their dependants’. Clinicians did not totally accept the
recommendation after the change, and this attitude wor-
sened over time. Poor attitude to and lower use of SP
for self-treatment was more apparent in hospitals and
non-public health facilities. These findings indicate that
other factors than provider’s attitude may play important
role in providers’ practices and acceptance of new treat-
ment recommendations. Such things as experience
acquired through observation of clinical response to
treatment, having a range of available treatment choices
and patients’ characteristics may have more influence in
clinical practices.
The need for close monitoring of implementation of
new treatment policies is emphasized including assess-
ment of training and sensitization needs for different
health worker cadres and facility type, particularly earlyin the change process. Training should involve refresher
trainings, especially in contents that seem not to be well
adhered to.
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